Dynavax Technologies Total Current Liabilities

Dynavax Technologies (DVAX) currently reports a total current liabilities of $110M as of September 2025. That compares with $70M in the prior-year period — up 52.6% year over year. Use the charts on this page to explore Dynavax Technologies's total current liabilities history and peer comparisons.

Dynavax Technologies's total current liabilities increased from $70M to $110M — a 52.6% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dynavax Technologies reported $110M in total current liabilities as of September 2025. That compares with $70M in the prior-year period — up 52.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Dynavax Technologies, and consider following DVAX for alerts when major investors trade the stock.

Dynavax Technologies is classified in the Healthcare sector. On total current liabilities, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DVAX with unrelated industries.